Cytosine base editor-mediated SOCS2 knockout promotes C2C12 cell differentiation via the PI3K/AKT/mTOR signaling

Y Wang1,2,3, C J Zhang2,3, Y X Li2,3

  • 1College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095 , China.

PubMed

Insights

Suppressor of cytokine signaling 2 (SOCS2) knockout using Cytosine Base Editor (CBE) promotes skeletal muscle development. This enhances myoblast differentiation and activates key growth signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • Skeletal muscle development involves myoblast differentiation and fusion.
  • The role of suppressor of cytokine signaling 2 (SOCS2) in myogenesis is not fully understood.

Purpose of the Study:

  • To investigate the specific function of SOCS2 in skeletal muscle development using the Cytosine Base Editor (CBE) system.
  • To elucidate the molecular mechanisms by which SOCS2 regulates myoblast differentiation.

Main Methods:

  • Designed sgRNAs targeting the murine SOCS2 gene for CBE-mediated gene editing in C2C12 myoblasts.
  • Established monoclonal cell lines with a SOCS2 premature stop codon mutation.
  • Utilized Western blot, immunofluorescence, differentiation assays, and proteomic sequencing to analyze gene and protein expression and signaling pathways.

Main Results:

  • CBE efficiently introduced a premature stop codon in SOCS2, significantly reducing protein expression.
  • SOCS2 knockout enhanced C2C12 myoblast differentiation, upregulating myogenic markers (MyoD1, MyoG, MYH1).
  • SOCS2 deficiency led to increased Growth Hormone Receptor (GHR) levels and activation of the PI3K/AKT/mTOR signaling pathway.

Conclusions:

  • Cytosine Base Editor-mediated SOCS2 knockout promotes C2C12 cell differentiation.
  • SOCS2 negatively regulates skeletal muscle development by inhibiting the PI3K/AKT/mTOR pathway.
  • This study provides new insights into the molecular regulation of skeletal muscle formation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K